Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
160.12
-2.43 (-1.49%)
Streaming Delayed Price
Updated: 2:23 PM EDT, May 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,434,047
Open
162.14
Bid (Size)
160.12 (1)
Ask (Size)
160.15 (2)
Prev. Close
162.55
Today's Range
159.87 - 162.90
52wk Range
130.96 - 182.89
Shares Outstanding
N/A
Dividend Yield
3.70%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
May 07, 2024
Investors concerned about broader market undulations may want to consider the resilience narrative of these biotech stocks to buy.
Via
InvestorPlace
AbbVie Tracking for New Highs in 2024
May 07, 2024
Future Dividend King AbbVie is tracking for new highs as the shift away from Humira-based business gains momentum with new treatments and acquisitions.
Via
MarketBeat
Topics
Earnings
Exposures
Financial
Performance
YTD
+0.19%
+0.19%
1 Month
-5.70%
-5.70%
3 Month
-7.60%
-7.60%
6 Month
+12.64%
+12.64%
1 Year
+8.59%
+8.59%
More News
Read More
3 Biotech Stocks to Double Your Money in the Next 24 Months
May 06, 2024
Via
InvestorPlace
3 Reasons to Buy AbbVie Stock on the Dip
May 05, 2024
Via
The Motley Fool
MarketBeat Week in Review – 4/29 - 5/3
May 04, 2024
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,100 Today
May 02, 2024
Via
Benzinga
Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
April 29, 2024
Via
Benzinga
7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns
April 30, 2024
Via
InvestorPlace
Analyst Sentiment, Revenue Growth Will Lead AbbVie Stock Higher
April 30, 2024
Via
MarketBeat
Inflation-Proof Fortunes: 7 Dividend Aristocrats to Keep Your Wealth Growing
April 30, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Interest Rates
AbbVie Outlook: Why Humira Biosimilars Won't Undo A Projected $73 Billion In Sales
April 29, 2024
Via
Investor's Business Daily
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Better Dividend Stock: AbbVie or Johnson & Johnson?
April 28, 2024
Via
The Motley Fool
3 Dividend Stocks to Buy and Hold for the Next Decade
April 27, 2024
Via
The Motley Fool
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
April 26, 2024
Via
The Motley Fool
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
April 26, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost
April 26, 2024
Via
Benzinga
Tech Stocks Rebound As Magnificent 7 Roar On Strong Earnings, Energy Giants Tumble: What's Driving Markets Friday?
April 26, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
ABBV Stock Earnings: AbbVie Beats EPS, Beats Revenue for Q1 2024
April 26, 2024
Via
InvestorPlace
Ex-Humira Growth Platform Drives AbbVie's Q1 Performance, Drugmaker Lifts Annual Profit Outlook
April 26, 2024
Via
Benzinga
AbbVie Beats First-Quarter Views As Skyrizi Looks To Take Humira's Title
April 26, 2024
Via
Investor's Business Daily
Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn't Over Yet
April 26, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
April 25, 2024
Via
Benzinga
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
April 25, 2024
Via
InvestorPlace
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
April 23, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.